Publication

Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival analysis of KEYNOTE-006.

Blank, C
Schachter, J
Robert, C
Ribas, A
Long, G
Arance, A
Mortier, L
Daud, A
Carlino, M
... show 10 more
Keywords
Type
Meetings and Proceedings
Citation
Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival analysis of KEYNOTE-006. 2016, 26: E117-E118 Melanoma Res
Journal Title
Journal ISSN
Volume Title
Embedded videos